Allogene stock forecast
WebApr 10, 2024 · Allogene Therapeutics (ALLO) Price Targets Enter Symbol Price Target Based on short-term price targets offered by 15 analysts, the average price target for … Web1 day ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Allogene Therapeutics (ALLO)
Allogene stock forecast
Did you know?
WebWhat are analysts forecasts for Allogene Therapeutics stock? The 22 analysts offering price forecasts for Allogene Therapeutics have a median target of 22.59, with a high estimate of 45.00 and a ... WebApr 10, 2024 · ALLO Earnings Date and Information. Allogene Therapeutics last issued its earnings results on February 28th, 2024. The reported ($0.66) EPS for the quarter, topping analysts' consensus estimates of ($0.71) by $0.05. The company earned $0.05 million during the quarter, compared to analysts' expectations of $0.06 million.
WebA. While ratings are subjective and will change, the latest Allogene Therapeutics ( ALLO) rating was a maintained with a price target of $29.00 to $23.00. The current price Allogene Therapeutics ... WebMar 17, 2024 · Allogene Therapeutics stock price target cut to $21 from $30 at B. Riley Feb. 28, 2024 at 8:29 a.m. ET by Tomi Kilgore Biotech and Pharma Cathie Wood’s Ark Funds Built Up Big Stakes in Crispr...
WebAllogene Therapeutics, Inc. (ALLO) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 4.8900 -0.0500 (-1.01%) At close: 04:00PM EDT 4.8900 0.00 … WebApr 10, 2024 · From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $190k. The company’s revenue is forecast to drop by …
WebJan 13, 2024 · Below on the page is a graph of the consensus forecast for Allogene Therapeutics stock for the next month. (30 days). The gray color on the chart shows the historical price of the stock. The turquoise color shows the price forecast with a possible range of fluctuations.
WebFeb 27, 2024 · Allogene Therapeutics (ALLO) stock forecast for 2026 Last update: February 27, 2024 (12:50) Sector: Healthcare The share price of Allogene Therapeutics, Inc. (ALLO) now What analysts predict: $22.69 52-week High/Low: $17.49 / $5.41 50/200 Day Moving Average: $6.86 / $10.19 This figure corresponds to the Average Price over … buffington highspireWeb2 days ago · SOUTH SAN FRANCISCO, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company … crohns albuminWebMar 13, 2024 · Allogene Therapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Allogene Therapeutics analysts is $ 18.81. Today 200 Day Moving Average is … buffington homebuilding group ltdWebApr 4, 2024 · Allogene Therapeutics's earnings is forecast to decline at an annual rate of 3.9% and its revenue is expected to decline at 60.5% annually. EPS and ROE are … buffington home improvementsWebApr 12, 2024 · Allogene Therapeutics Inc Stock Add to Watchlist Overview Forecast Earnings Dividend Ownership $5.51 -0.15 (-2.65%) Updated Mar 16, 2024 1W - 4.84% 1M - 21.4% 3M - 20.26% 1Y - 34.33% ALLO Price $5.51 Fair Value Price $5.94 Market Cap $796.18M 52 Week Low $5.36 52 Week High $17.49 P/E -2.38x P/B 1.2x P/S 3,705.34x … buffington homes austin jobsWeb11 hours ago · Teva Pharmaceutical Industries Ltd. (TEVA) : Free Stock Analysis Report. Kala Pharmaceuticals, Inc. (KALA) : Free Stock Analysis Report. Allogene Therapeutics, Inc. (ALLO) : Free Stock Analysis Report buffington homesWeb1 day ago · All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ... buffington homes austin